| Members |
targetComponentId |
| Acyclovir 400mg dispersible tablet |
Aciclovir 400 mg oral tablet |
| Acyclovir 800mg dispersible tablet |
Aciclovir 800 mg oral tablet |
| Addison's disease, NOS |
Addison's disease |
| Additional general conditions of patient |
Clinical finding (finding) |
| Additional preoperative procedure instituted by anesthetist |
Preoperative procedure |
| Additional preoperative therapy instituted by anesthetist |
Preoperative procedure |
| Adductor digiti minimi muscle of hand |
Structure of abductor digiti minimi muscle of hand (body structure) |
| Adenocarcinoid tumor |
Well-differentiated neuroendocrine tumor (morphologic abnormality) |
| Adenocarcinoid tumour |
Well-differentiated neuroendocrine tumor (morphologic abnormality) |
| Adenocarcinoma and squamous carcinoma histologic grade |
Histologic grade of neoplasm (observable entity) |
| Adenocarcinoma, no subtype |
Adenocarcinoma (morphologic abnormality) |
| Adenocarcinoma, no subtype, high grade |
High grade adenocarcinoma (morphologic abnormality) |
| Adenocarcinoma, no subtype, intermediate grade |
Intermediate grade adenocarcinoma (morphologic abnormality) |
| Adenocarcinoma, no subtype, low grade |
Low grade adenocarcinoma (morphologic abnormality) |
| Adenofibroma, no International Classification of Diseases for Oncology subtype |
Benign adenofibroma (morphologic abnormality) |
| Adenoma, no subtype |
Adenoma (morphologic abnormality) |
| Adenosine 3mg/mL infusion solution 10mL vial |
Product containing precisely adenosine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Adhesiolysis - action |
Dissection - action |
| Adipose tissue reduction operation NOS |
Adipose tissue reduction operation |
| Adipose tissue reduction operation NOS |
Adipose tissue reduction operation |
| Adjudicator NOS |
Adjudicator |
| Adjudicator NOS |
Adjudicator |
| Adjustment of external splintage |
Adjusting of splint |
| Adjustment reaction in infancy |
Adjustment reaction in infancy (disorder) |
| Adjustment reaction of adolescence |
Adjustment reaction of adolescence (disorder) |
| Adjustment reaction of adult life |
Adjustment reaction of adult life (disorder) |
| Adjustment reaction of childhood |
Adjustment reaction of childhood (disorder) |
| Adjustment reaction of late life |
Adjustment reaction of late life (disorder) |
| Adjustment to prosthesis in organ NOC |
Prosthetic readjustment |
| Adjustments to denture by other than dentist providing appliances |
Adjust denture |
| Administration |
Introduction procedure (procedure) |
| Administration |
Introduction procedure (procedure) |
| Administration |
Introduction procedure (procedure) |
| Administration |
Introduction procedure (procedure) |
| Administration by chaplain of last rites to dying patient |
Administration of last rites (regime/therapy) |
| Administration of RhD immune globulin |
Administration of human anti-D immunoglobulin (procedure) |
| Administration of RhD immune globulin declined |
Administration of human anti-D immunoglobulin declined |
| Administration of anesthesia for obstetric procedure |
Administration of anesthesia (procedure) |
| Administration of anesthesia for procedure |
Administration of anesthesia (procedure) |
| Administration of contaminated substance NOS |
Medical accident to patient during surgical and medical care (event) |
| Administration of contaminated substance NOS |
Medical accident to patient during surgical and medical care (event) |
| Administration of other contaminated substance |
Medical accident to patient during surgical and medical care (event) |
| Administration of prescribed medications and solutions |
Administration of medication |
| Administration of prescribed medications based on arterial blood gas results |
Administration of medication |
| Administration of skin test by nurse |
Skin test |
| Administration of substance |
Introduction procedure (procedure) |
| Administration of substance by intravenous piggyback |
Administration via intravenous route (procedure) |
| Administration of substance into bladder via intravesical route |
Administration into urinary bladder via intravesical route |
| Administration of substance via enteral route |
Administration via enteral route (procedure) |
| Administration of substance via gastroenteral route |
Administration via gastroenteral route |
| Administration of substance via intraarterial route |
Administration via intraarterial route |
| Administration of substance via intravenous route |
Administration via intravenous route (procedure) |
| Administration of substance via oral route |
Administration via oral route (procedure) |
| Administration of substance via specific route |
Administration via specific route |
| Administration of substance via subcutaneous route |
Administration via subcutaneous route |
| Administration of substance via topical route |
Administration via topical route |
| Administration of substance via vaginal route |
Medication administration: vaginal |
| Administration of syntometrine |
Administration of ergometrine and oxytocin |
| Administration of therapeutic medication |
Administration of medication |
| Administration of therapeutic substance |
Administration of medication |
| Administration of therapeutic substance |
Administration of medication |
| Administration of therapeutic substance into artery |
Administration via intraarterial route |
| Administration of vaccine product containing only Human papillomavirus 9 antigen |
Administration of Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine |
| Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens |
Administration of pneumococcal 13-valent conjugate vaccine |
| Administrative and indirect care procedures |
Procedure |
| Admission funding status NOS |
Admission funding status |
| Admission funding status NOS |
Admission funding status |
| Admit hospital emergency NOS |
Emergency hospital admission |
| Admit hospital emergency NOS |
Emergency hospital admission |
| Admit medical emergency unspecified |
Emergency hospital admission |
| Admit medical emergency unspecified |
Emergency hospital admission |
| Admit surgical emergency unspecified |
Emergency hospital admission |
| Admit surgical emergency unspecified |
Emergency hospital admission |
| Admit to intensive c.u. NOS |
Admission to intensive care unit |
| Admit to intensive care unit NOS |
Admission to intensive care unit |
| Adrenal cortex agent |
Adrenal cortex hormone |
| Adrenal cortical adenoma - category |
Benign adrenal cortical adenoma (morphologic abnormality) |
| Adrenal cortical adenoma, no International Classification of Diseases for Oncology subtype |
Benign adrenal cortical adenoma (morphologic abnormality) |
| Adrenal hormone agent |
Adrenal hormone |
| Adrenaline 0.5% eye drops |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution |
| Adrenaline 1:1000 500micrograms/0.5mL injection |
Adrenaline 1 mg/mL nasal solution |
| Adult Kienbock's disease of bilateral lunate |
Progressive avascular necrosis of bilateral lunate bones (disorder) |
| Adult disease |
Disease |
| Adult periodontitis |
Chronic periodontitis |
| Adult rhabdomyoma |
Adult cellular rhabdomyoma (morphologic abnormality) |
| Adult screening NOS |
Adult screening |
| Adult screening NOS |
Adult screening |
| Adult type granulosa cell tumor of testis |
Adult type granulosa cell tumor of uncertain behavior (morphologic abnormality) |
| Advance care planning request by patient |
Subject requested advance care planning (situation) |
| Advancement of flap graft |
Reconstruction using local advancement flap (procedure) |
| Advancement of mucosa of lip NEC |
Advancement of mucosa of lip (procedure) |
| Adverse effect of oral diphosphonate |
Adverse reaction caused by bisphosphonate (disorder) |
| Adverse effects NEC |
Adverse reaction (disorder) |
| Adverse effects NOS |
Adverse reaction (disorder) |
| Adverse health risk due to absence of sink in residence |
Lack of functioning sink in residence (finding) |
| Adverse health risk due to absence of toilet in residence |
Lack of functioning toilet in residence |
| Adverse health risk due to asbestos in residence |
Asbestos in residence (finding) |
| Adverse health risk due to carbon monoxide in residence |
Carbon monoxide in residence |
| Adverse health risk due to infestation of residence |
Infestation of place of residence (finding) |
| Adverse health risk due to lack of equipment for safe food storage in residence |
Inadequate equipment for safe food storage in residence |
| Adverse health risk due to lack of food preparation equipment in residence |
Inadequate food preparation equipment in residence (finding) |